ReviewMolecules (Basel, Switzerland)2020
Recent Advances in Asymmetric Iron Catalysis.
Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Imidazol-2-ylidene-Based NCCN Ligands for Chiral-at-Iron Catalysis.Organometallics · 2026Article
- An Achiral Tetradentate Cis-α-Coordinating NCCN Ligand Gives Rise to a Configurationally Stable Chiral-at-Iron Complex for Enantioselective Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Iron-catalysed radical difunctionalization of alkenes.Nature synthesis · 2025Article
- Mechanistic and Computational Insights into Asymmetric Intramolecular Iron-Catalyzed Nitrene Transfer into Benzylic C─H Bonds.ACS catalysis · 2025Article
- βOrganic letters · 2024Article
- Mild Iron-Catalyzed Oxidative Cross-Coupling of Quinoxalinones with Indoles.Molecules (Basel, Switzerland) · 2024Article
- Iron-catalyzed stereoselective C-H alkylation for simultaneous construction of C-N axial and C-central chirality.Nature communications · 2024Article
- Insight into Radical Initiation, Solvent Effects, and Biphenyl Production in Iron-Bisphosphine Cross-Couplings.ACS catalysis · 2023Article
- Iron(II) Complex with a Silacycle-Bridged Biaryl-Based Ligand.ACS omega · 2023Article
- Improving the Configurational Stability of Chiral-at-Iron Catalysts Containing TwoOrganometallics · 2022Article
- Recyclable Mn(I) Catalysts for Base-Free Asymmetric Hydrogenation: Mechanistic, DFT and Catalytic Studies.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022Article
- Mn(I) phosphine-amino-phosphinites: a highly modular class of pincer complexes for enantioselective transfer hydrogenation of aryl-alkyl ketones.Dalton transactions (Cambridge, England : 2003) · 2021Article
- Chiral-at-Iron Catalyst for Highly Enantioselective and Diastereoselective Hetero-Diels-Alder Reaction.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asymmetric transition-metal catalysis represents a fascinating challenge in the field of organic chemistry research. Since seminal advances in the late 60s, which were finally recognized by the Nobel Prize to Noyori, Sharpless and Knowles in 2001, the scientific community explored several approaches to emulate nature in producing chiral organic molecules. In a scenario that has been for a long time dominated by the use of late-transition metals (TM) catalysts, the use of 3d-TMs and particularly iron has found, recently, a widespread application. Indeed, the low toxicity and the earth-abundancy of iron, along with its chemical versatility, allowed for the development of unprecedented and more sustainable catalytic transformations. While several competent reviews tried to provide a complete picture of the astounding advances achieved in this area, within this review we aimed to survey the latest achievements and new concepts brought in the field of enantioselective iron-catalyzed transformations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.